CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial Post author: Post published:April 25, 2024 Post category:News Feed Post comments:0 Comments Researchers have published results of a phase I clinical trial of a novel immunotherapy for high-risk sarcomas. You Might Also Like Exercise improves brain function, possibly reducing dementia risk January 24, 2025 Interactions between flu subtypes predict epidemic severity more than virus evolution February 14, 2024 Researchers develop more broadly protective coronavirus vaccine April 3, 2024 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.
Interactions between flu subtypes predict epidemic severity more than virus evolution February 14, 2024